glp 1 and gip glp 1 receptor agonists Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research Comparison between GLP-1 RA and
Description
They found that GLP-1 use was associated with about 7 fewer people per 1,000 developing any substance-use disorder over the study period of three years
Main GLP1 and Related Brands Leading GLP-1 medications in 2025 include semaglutide (marketed as Ozempic for diabetes and Wegovy for weight loss), liraglutide (Victoza for diabetes, Saxenda for weight loss), tirzepatide (Mounjaro for diabetes, Zepbound for weight loss), dulaglutide (Trulicity for diabetes) and oral semaglutide (Rybelsus)

These problems may affect a persons quality of life, leading to missed work and increased hospital visits

Age was inversely correlated with older populations having lower risk of psychiatric comorbidity

Here's Why Some people on GLP-1 medication notice they simply dont want to drink anymore
